跳至主要内容
临床试验/CTRI/2025/02/080622
CTRI/2025/02/080622尚未招募2 期

Effect of vitamin D supplementation on serum levels of pigment epithelium derived factors and vascular endothelium growth factors in patients of Diabetic Retinopathy

Institute of Ophthalmology JNMC, AMU1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年2月28日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
serum levels of vascular endothelial growth factor and pigment epithelial derived growth factor after vitamin D supplementation

研究概览

简要总结

This is a Randomized triple blinded parallel group study to determine the effect of Vitamin D3 supplementation on the serum levels of vascular endothelial growth factor and pigment epithelial derived factor in patients of Diabetic retinopathy for a period of 12 weeks in 120 patients that will be conducted at one center in India. the primary outcomes measures will be serum levels of vascular endothelial growth factor and pigment epithelial derived factor after vitamin D supplementation. the secondary outcomes will be serum levels of methylglyoxal in various grades of diabetic retinopathy.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients with Non Proliferative and Proliferative Diabetic Retinopathy.

排除标准

  • Patients receiving vitamin D and calcium supplements.
  • Patients taking any other medication that could change vitamin D metabolism, such as Rifampicin or Phenytoin.
  • Patients with very low vitamin D / sufficient vitamin levels iv.
  • patients who have recieved injection antiVEGF for past 3 months v.
  • patients who have recieved laser in retina for past 1 month.

结局指标

主要结局

serum levels of vascular endothelial growth factor and pigment epithelial derived growth factor after vitamin D supplementation

时间窗: 12 weeks

次要结局

  • serum levels of vascular endothelial growth factor and pigment epithelial derived growth factor in various grades of diabetic retinopathy(12 weeks)

研究者

发起方
Institute of Ophthalmology JNMC, AMU
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Prof SIMI ZAKAURRAB

AMUIO, JNMCH, AMU, Aligarh

研究点 (1)

Loading locations...

相似试验